Renal denervation systems from both Medtronic and Recor have been approved for Transitional Pass-Through (TPT) payment by the Centers for Medicare and Medicaid Services, the companies announced last week.
News We’re Watching: Medicare Payments For Renal Denervation; Acquisitions for Tempus And Boston Sci; LumiThera And Caris Land FDA Authorizations
This week, renal denervation systems from Medtronic and Recor won Medicare coverage; Boston Scientific bought cardiac-mapping firm Cortex; Veravas and Phanes Biotech teamed up on an Alzheimer’s diagnostic; and more.
